StemGen (SGNI) Stock Statistics & Valuation Metrics
Total Valuation
StemGen has a market cap or net worth of $4,567.00. The enterprise value is $5.13T.
- Market Cap
- $4,567.00
- Enterprise Value
- $5.13T
Share Statistics
StemGen has 45,671,062 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 45,671,062
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
StemGen’s return on equity (ROE) is 0.32 and return on invested capital (ROIC) is 31.65%.
- Return on Equity (ROE)
- 0.32
- Return on Assets (ROA)
- -1.08
- Return on Invested Capital (ROIC)
- 31.65%
- Return on Capital Employed (ROCE)
- 0.18
- Revenue Per Employee
- 39.00K
- Profits Per Employee
- -433.00K
- Employee Count
- 1
- Asset Turnover
- 0.10
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of StemGen is -10.53. StemGen’s PEG ratio is 0.23.
- PE Ratio
- -10.53
- PS Ratio
- 117.11
- PB Ratio
- -3.42
- Price to FCF
- -32.35
- Price to Operating Cash Flow
- -32.30
- PEG Ratio
- 0.23
Income Statement
In the last 12 months, StemGen had revenue of 39.00K and earned -433.00K in profits. Earnings per share was -0.01.
- Revenue
- 39.00K
- Gross Profit
- 8,546
- Operating Income
- -244.00K
- Pretax Income
- -433.00K
- Net Income
- -433.00K
- EBITDA
- -179.87K
- Earnings Per Share (EPS)
- -0.01
Cash Flow
In the last 12 months, operating cash flow was -259.74K and capital expenditures 0, giving a free cash flow of -259.74K billion.
- Operating Cash Flow
- -259.74K
- Free Cash Flow
- -259.74K
- Free Cash Flow per Share
- -0.00
Dividends & Yields
StemGen pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -3.09%
- Earnings Yield
- -9.50%
Stock Price Statistics
- Beta
- 0.00
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.10
- 200-Day Moving Average
- 0.10
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Financial Position
StemGen as a current ratio of 0.00, with Debt / Equity ratio of -42.22%
- Current Ratio
- 0.00
- Quick Ratio
- 0.00
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- -3.12
- Interest Coverage Ratio
- -1.73
Taxes
In the past 12 months, StemGen has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
StemGen EV to EBITDA ratio is -28.52, with an EV/FCF ratio of -36.33.
- EV to Sales
- 131.51
- EV to EBITDA
- -28.52
- EV to Free Cash Flow
- -36.33
- EV to Operating Cash Flow
- -36.33
Balance Sheet
StemGen has $22.87K in cash and marketable securities with $563.20K in debt, giving a net cash position of -$540.33K billion.
- Cash & Marketable Securities
- $22.87K
- Total Debt
- $563.20K
- Net Cash
- -$540.33K
- Net Cash Per Share
- -$0.01
- Tangible Book Value Per Share
- -$0.04
Margins
Gross margin is 21.91%, with operating margin of -625.64%, and net profit margin of -1110.26%.
- Gross Margin
- 21.91%
- Operating Margin
- -625.64%
- Pretax Margin
- -1110.26%
- Net Profit Margin
- -1110.26%
- EBITDA Margin
- -461.19%
- EBIT Margin
- -748.72%
Analyst Forecast
The average price target for StemGen is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―